| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3956(97)00012-5 |
| P698 | PubMed publication ID | 9793871 |
| P2093 | author name string | Lane A | |
| Larkin C | |||
| O'Callaghan E | |||
| Buckley PF | |||
| Waddington JL | |||
| Scully PJ | |||
| P2860 | cites work | Is schizophrenia a neurodevelopmental disorder? | Q22337044 |
| Child development risk factors for adult schizophrenia in the British 1946 birth cohort | Q28241350 | ||
| Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
| Monozygotic twins with 22q11 deletion and discordant phenotypes | Q33683257 | ||
| Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. | Q33992163 | ||
| Subtype progression and pathophysiologic deterioration in early schizophrenia | Q34061795 | ||
| The mortality and morbidity associated with umbilical cord prolapse | Q34294623 | ||
| Risk factors and infant outcomes associated with umbilical cord prolapse: a population-based case-control study among births in Washington State | Q34336332 | ||
| Predictors of human gestational length | Q34360806 | ||
| Recent advances in primary palate and midface morphogenesis research | Q35567234 | ||
| Minor congenital anomalies and ataxic cerebral palsy | Q35624531 | ||
| Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study | Q35824494 | ||
| Neuroleptics and the Natural Course of Schizophrenia | Q36515362 | ||
| The positive-negative distinction in schizophrenia. Review of natural history validators | Q36729280 | ||
| Course of schizophrenia: neuropsychological evidence for a static encephalopathy | Q36762199 | ||
| Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11 | Q36886713 | ||
| Neuromotor precursors of schizophrenia | Q38484637 | ||
| Are complications of pregnancy and birth causes of schizophrenia? | Q39514102 | ||
| Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia | Q39695850 | ||
| Developmentally moderated expressions of the neuropathology underlying schizophrenia | Q40394702 | ||
| From neuropathology to neurodevelopment | Q40403712 | ||
| Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients | Q40511323 | ||
| Schizophrenia: developmental neuroscience and pathobiology | Q40708357 | ||
| Increased rate of P300 latency prolongation with age in schizophrenia. Electrophysiological evidence for a neurodegenerative process | Q40980933 | ||
| Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration | Q41097850 | ||
| Obstetric complications and schizophrenia: a meta-analysis | Q41130263 | ||
| Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study | Q41161557 | ||
| Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. | Q41376137 | ||
| Childhood behavioral precursors of adult symptom dimensions in schizophrenia | Q41670661 | ||
| A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). | Q42632985 | ||
| Monozygotic twins with chromosome 22q11 deletion and discordant phenotype | Q42668051 | ||
| Monozygotic twins with chromosome 22q11 deletion and discordant phenotype | Q43505829 | ||
| A population-based case-control study of risk factors for breech presentation | Q43664194 | ||
| The palate and Down's syndrome | Q44540624 | ||
| Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. | Q44762879 | ||
| Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. | Q45173483 | ||
| Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 | ||
| Minor congenital defects in children of low birth weight | Q47375183 | ||
| Brain anomalies in velo-cardio-facial syndrome | Q48105454 | ||
| Is there cognitive decline in schizophrenia? A cross-sectional study | Q48148195 | ||
| Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia | Q48186308 | ||
| Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings | Q48274081 | ||
| Neurodevelopmental significance of minor and major congenital anomalies in neonatal high risk children | Q48346529 | ||
| Minor physical anomalies in schizophrenia and mood disorders | Q48380740 | ||
| Neuropsychological functioning of first-episode schizophreniform patients | Q48459675 | ||
| The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins | Q48626858 | ||
| Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients | Q48633690 | ||
| Executive (frontal) dysfunction and negative symptoms in schizophrenia: apparent gender differences in 'static' v. 'progressive' profiles | Q48641205 | ||
| Bilateral destruction of the fetal paraventricular nuclei prolongs gestation in sheep | Q48669041 | ||
| Multiple minor malformations as a marker for prenatal etiology of cerebral palsy | Q48678817 | ||
| Human fetal hippocampal development: I. Cytoarchitecture, myeloarchitecture, and neuronal morphologic features | Q49037695 | ||
| Early childhood psychosis and bleeding during pregnancy. A prospective study of gravid women and their offspring | Q50310606 | ||
| The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging. | Q51041954 | ||
| The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients. | Q52016780 | ||
| Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. | Q52018715 | ||
| 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. | Q52055580 | ||
| Antecedents of cerebral palsy. Multivariate analysis of risk. | Q52078274 | ||
| Soft-palate myogenesis: a developmental field paradigm. | Q52223312 | ||
| Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients | Q52229508 | ||
| Chidhood precursors of psychiosis as clues to its evolutionary orgins | Q52916248 | ||
| Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia | Q57422558 | ||
| All out for chromosome six | Q59039599 | ||
| Positive and negative symptoms/syndromes in schizophrenia: reliability and validity of different diagnostic systems | Q60460849 | ||
| The effect of hypothalamic lesions on the length of gestation in fetal sheep | Q61865406 | ||
| Association between maternal bleeding during gestation and congenital anomalies in the offspring | Q67441845 | ||
| Negative symptoms and the early course of schizophrenia | Q67584218 | ||
| Perinatal outcome of pregnancies complicated by vaginal bleeding | Q67980022 | ||
| Duration of psychosis and outcome in first-episode schizophrenia | Q68016105 | ||
| Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia | Q68166789 | ||
| Minor physical anomalies in schizophrenia | Q69604870 | ||
| A randomised controlled trial of prophylactic neuroleptic treatment | Q69879930 | ||
| Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality | Q69907420 | ||
| Familial, obstetric, and other clinical correlates of minor physical anomalies in schizophrenia | Q70122276 | ||
| A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings | Q70862901 | ||
| Course of treatment response in first-episode and chronic schizophrenia | Q70996304 | ||
| Symptom stability in geriatric chronic schizophrenic inpatients: a one-year follow-up study | Q71284801 | ||
| Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia | Q71538897 | ||
| Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia | Q71559346 | ||
| Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype | Q71569702 | ||
| Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia | Q71600080 | ||
| Early intervention for schizophrenia: can the course of the illness be altered? | Q71716492 | ||
| Early gestational bleeding and pregnancy outcome: a multivariable analysis | Q71795208 | ||
| Link between pregnancy complications and minor physical anomalies in monozygotic twins discordant for schizophrenia | Q72074915 | ||
| Birth defects in relation to threatened abortion | Q72077091 | ||
| Obstetric complications as antecedents of schizophrenia: empirical effects of using different obstetric complication scales | Q72117156 | ||
| The deficit state in first-episode schizophrenia | Q72204983 | ||
| Epidemiology of preterm birth | Q72401091 | ||
| Does growth retardation predispose the fetus to congenital malformation? | Q72520050 | ||
| Genetics, chance and dysmorphogenesis in schizophrenia | Q72570610 | ||
| Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone | Q72676838 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 179-189 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Journal of Psychiatric Research | Q6295810 |
| P1476 | title | Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics? | |
| P478 | volume | 32 |
| Q51915802 | Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders: timing and patterns. |
| Q57496450 | Determining Pro-Oxidant Antioxidant Balance (PAB) and Total Antioxidant Capacity (TAC) in Patients with Schizophrenia |
| Q28513404 | Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screen |
| Q52171892 | Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process. |
| Q28743868 | MRI study of minor physical anomaly in childhood autism implicates aberrant neurodevelopment in infancy |
| Q45296883 | Minor physical anomalies and craniofacial measures in patients with treatment-resistant schizophrenia |
| Q41743488 | Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease? |
| Q77482059 | New views on the course and treatment of schizophrenia |
| Q34270701 | Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition |
| Q48711197 | Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome |
| Q51966487 | Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics. |
| Q33338398 | Schizophrenia: solving the puzzle |
| Q33679792 | The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease |
Search more.